NPR logo
FDA Panel Rejects OTC Cholesterol Drug
  • Download
  • <iframe src="https://www.npr.org/player/embed/4285604/4285605" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
FDA Panel Rejects OTC Cholesterol Drug

Health Care

FDA Panel Rejects OTC Cholesterol Drug

FDA Panel Rejects OTC Cholesterol Drug
  • Download
  • <iframe src="https://www.npr.org/player/embed/4285604/4285605" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

An FDA advisory panel rejects Merck's proposal to sell a cholesterol-lowering drug without a prescription. The FDA complained that a proposed label for the product is not informative enough, and that an OTC statin might create false confidence in consumers. NPR's Allison Aubrey reports.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.